Is Ozempic or Zepbound Better for Weight Loss?

Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The choice between Ozempic (semaglutide) and Zepbound (tirzepatide) depends on your individual physiology, weight loss goals, and how your body responds to single versus dual-hormone therapies. Clinical trials show tirzepatide users lost up to 22% of body weight compared to 15% with semaglutide, but individual results vary significantly based on genetic and metabolic factors.

How Ozempic and Zepbound Work Differently in Your Body

Ozempic contains semaglutide, a GLP-1 receptor agonist that signals your brain to reduce hunger and increases feelings of fullness after eating smaller portions. It works by mimicking glucagon-like peptide-1, a natural hormone your body produces that regulates appetite and blood sugar.

Zepbound delivers tirzepatide, a dual GLP-1 and GIP receptor agonist that activates two separate hunger-control pathways simultaneously. By targeting both the GLP-1 and glucose-dependent insulinotropic peptide receptors, tirzepatide engages a broader mechanism than single-hormone therapies, which explains its higher average weight loss outcomes in head-to-head trials.

Weight Loss Results: Clinical Evidence for Each Medication

Semaglutide clinical trials demonstrated average weight loss of 15% of body weight over 68 weeks when combined with lifestyle modification, with some patients achieving up to 18% reduction. The STEP trials established semaglutide's safety profile across diverse populations and showed consistent results across multiple dose levels.

Tirzepatide produced average weight loss of 22% of body weight in the SURMOUNT trials, with some participants losing up to 24% of their initial weight. The dual-receptor mechanism appears to produce stronger appetite suppression and metabolic effects, though response varies based on individual genetic predispositions affecting peptide sensitivity.

Side Effects and Tolerability Differences Between the Two

Both medications share common GLP-1 side effects including nausea, vomiting, constipation, and diarrhea, typically occurring during dose escalation and diminishing over time. Semaglutide generally shows slightly milder gastrointestinal effects in some patients, while tirzepatide's dual-hormone action occasionally produces stronger initial side effects that usually resolve within weeks.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Choosing Your Medication: Personalized GLP-1 Therapy at PlexusDx

PlexusDx offers both compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan and compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, with your dose potentially increasing while your price remains fixed. Both formulations come from licensed 503A compounding pharmacies and work without insurance or membership requirements.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide stronger than semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I switch from Ozempic to Zepbound if one isn't working?

Yes, many patients transition between medications based on individual response. Some start with semaglutide and switch to tirzepatide for greater weight loss, while others move in the opposite direction due to side effect tolerance. Your PlexusDx clinician can guide this transition safely, typically spacing the switch over 1-2 weeks.

How much does PlexusDx tirzepatide cost compared to brand Zepbound?

PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan flat—no flat per-compound pricing increases. This is typically 40-60% less than brand Zepbound, works in all 50 states without insurance, and qualifies for HSA/FSA accounts.

Are compounded Ozempic and Zepbound as safe as brand versions?

PlexusDx medications come exclusively from licensed 503A compounding pharmacies, which follow strict FDA manufacturing standards. Compounded semaglutide and tirzepatide deliver the same active compounds as brand versions, though they're not FDA-approved as branded products. Your clinician monitors your response just as with brand medications.

How does the Precision Peptide Genetic Test help choose between these medications?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.